Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.03.24

Clean room block

Sai Life Sciences opens new clean room block at its manufacturing campus

Sai Life Sciences, one of India’s fastest growing Contract Research, Development & Manufacturing Organizations (CRDMOs), today announced the opening of a new Clean Room block at its cGMP API & Intermediate Manufacturing campus in Bidar, India.

Making the announcement, Krishna Kanumuri, CEO & Managing Director of Sai Life Sciences said, “Over the last two years we have been seeing an increase in projects involving commercial products, not just for regulatory starting materials and intermediates, but also final drug substances. This addition of latest generation clean rooms to our facilities expands our capacity while adding versatility to help serve the diverse needs of our customers.”

A notable aspect across all of the company’s infrastructure expansion over the past two years has been to make all new facilities uniformly capable of handling containment down to 1µg/m3. The new 8,500 sq. ft. Clean Room block is the newest addition to this list. Located in the Bidar Manufacturing Campus of the company, it has the following features:

• Four ISO-8 (Class 100,000) Clean Rooms operating at containment level of 1µg/m3 across the operation
• Four parallel crystallizer lines with complete segregation of AHU
• Five versatile dissolution reactors capable of handling various reactions, including if crystallization step is in situ with reaction
• Latest generation Wonderware automation which allows fine ramp control / distillation control to handle critical cooling crystallization and evaporative crystallization
• Versatile sizes of filtration, drying equipment (Filter dryers, Peeler centrifuge, Nauta dryer)
• Various material of construction (SS316, Hastelloy and Glass-lined).
• Separate line for size reduction.
• “Bubble design” with separate gowning / de-gowning areas and airlocks to enable multi-product handling.

Sai Life Sciences began a process of organizational transformation in 2019 reinventing itself as a new generation global CDMO. Through this initiative, named Sai Nxt, the company is investing over US$ 150M (> INR 1000 Cr) to expand and upgrade its R&D and manufacturing facilities, induct top-notch global scientific and leadership talent, strengthen automation and data systems, and above all raise the bar for safety, quality and customer focus.

Share article

More News

2025.11.27

India is evolving from being a tactical supplier to a strategic partner to global pharma

Krishna Kanumuri, MD & CEO of Sai Life Sciences, was recently interviewed by Pharmaceutical Executive for its feature on next-generation CDMOs. In the interview, he shares insights on how Indian CDMOs are evolving from tactical suppliers to strategic partners, the shifting global supply-chain landscape, and how Sai Life Sciences is preparing for the opportunities and […]
Read more

2025.11.27

Decoding the Signals of Life: CDFD’s Dr. Rashna Bhandari visits Sai

Dr. Rashna Bhandari, Principal Investigator at the Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad, recently visited our Sai Life Sciences campus to deliver an insightful masterclass on “Phosphate-rich biomolecules in cell signalling.” In her session, Dr. Bhandari explored how phosphate-rich molecules act as vital messengers that regulate cellular communication and coordination. She explained how […]
Read more

2025.11.08

SLSC_Sankalp

Sai Life Sciences Launches Child Safety Awareness Program in Government Schools in Hyderabad with Sankalp

Raising awareness around child safety requires sensitivity and a collective effort to help children recognize unsafe situations and know how to respond. Guided by this purpose, Sai Life Sciences, in partnership with Sankalp NGO, has launched a Child Sexual Abuse Prevention Program across ten government schools in Gachibowli, Hyderabad. The program features two age-appropriate curriculums […]
Read more

2025.11.07

Sai Life Sciences Limited

Sai Life Sciences Limited sustains growth momentum in Q2FY26

Revenue up by 36%; EBITDA up by 43%; Net Profit up by 100% Hyderabad, November 06, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), one of India’s fastest growing Contract Research, Development and Manufacturing Organizations (CRDMO) announced its financial results for the second quarter and half year ended September 2025. Financial Performance: Particulars […]
Read more

2025.11.05

Where Nature Inspires Innovation: University of Kansas Prof. Apurba Dutta visits Sai

Dr. Apurba Dutta, Associate Professor at Department of Medicinal Chemistry, University of Kansas, USA, recently visited our Sai Life Sciences campus to deliver a masterclass on “A serine-derived second-generation chiron: Applications in the synthesis of natural and nature-like molecular scaffolds.”During the session, he explored how simple natural molecules can serve as versatile building blocks for […]
Read more